Yamamoto Ryohei, Numakura Kazuyuki, Aoyama Yu, Okubo Keisuke, Sasagawa Hajime, Mori Kanami, Sekine Yuya, Sato Hiromi, Kobayashi Mizuki, Saito Mitsuru, Narita Shintaro, Habuchi Tomonori
Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
Department of Renal and Urologic Surgery, Asahikawa Medical University, 1-1-1 Midorigaoka-Higashi-2Jyo, Asahikawa, 078-8510, Japan.
J Robot Surg. 2025 Sep 12;19(1):595. doi: 10.1007/s11701-025-02775-7.
In 2002, the renal cancer T classification was revised by dividing T1 into T1a and T1b at a 4 cm cutoff. However, local treatment using minimally invasive procedures resulted in better outcomes for tumors smaller than 3 cm, leading the European Association of Urology guideline committee to propose a 3 cm cutoff for T1a/b. Nonetheless, the impact of changing the T1 cutoff on robot-assisted partial nephrectomy (RALPN) has not been fully investigated. This study included 300 out of 335 patients with clinical stage T1 disease who underwent RALPN at our institution between November 2013 and April 2024. We evaluated the discriminative performance of clinical outcomes in each group using tumor diameter cutoffs of 4 and 3 cm. Using a 3 cm cutoff, patients with tumors ≥ 3 cm showed a greater decline in estimated glomerular filtration rate (eGFR) (e.g., the change from baseline to 1-year follow-up) ( - 9.6% vs. - 4.9%, p = 0.003) and a higher incidence of overall complications (25% vs. 15%, p = 0.040) compared to those with smaller tumors. With a 4 cm cutoff, differences in eGFR decline ( - 7.8% vs. - 6.7%, p = 0.134) and overall complications (27% vs. 17%, p = 0.100) were not significant. The 3 cm cutoff more accurately predicted overall complications with a higher area under the curve (0.575 vs. 0.451, p = 0.037). A 3 cm cutoff for the T classification of kidney cancer may more accurately predict postoperative renal function and the risk of complications.
2002年,肾癌T分类进行了修订,将T1按4 cm的临界值分为T1a和T1b。然而,采用微创手术的局部治疗对小于3 cm的肿瘤产生了更好的疗效,促使欧洲泌尿外科学会指南委员会提出将T1a/b的临界值设为3 cm。尽管如此,改变T1临界值对机器人辅助肾部分切除术(RALPN)的影响尚未得到充分研究。本研究纳入了2013年11月至2024年4月期间在本机构接受RALPN的335例临床分期为T1期疾病患者中的300例。我们使用4 cm和3 cm的肿瘤直径临界值评估了每组临床结局的判别性能。采用3 cm临界值时,肿瘤≥3 cm的患者估计肾小球滤过率(eGFR)下降幅度更大(例如,从基线到1年随访的变化)(-9.6%对-4.9%,p = 0.003),总体并发症发生率更高(25%对15%,p = 0.040),与肿瘤较小的患者相比。采用4 cm临界值时,eGFR下降差异(-7.8%对-6.7%,p = 0.134)和总体并发症差异(27%对17%,p = 0.100)不显著。3 cm临界值能更准确地预测总体并发症,曲线下面积更高(0.575对0.451,p = 0.037)。肾癌T分类采用3 cm临界值可能更准确地预测术后肾功能和并发症风险。